ISR provides a geographic assessment of the CRO market based on the number of trials conducted in each country/region. One could hypothesize that the trials being conducted in North America are, on average, larger than those being conducted in South America. But without hard data to support the hypothesis, ISR decided to treat each trial equally.
Originally published in Life Science Leader.
View Resource